Otsuka’s Pharma Sales Grow 6.3% in January-September on Global Brands

Otsuka Holdings saw its pharma sales climb 6.3% year on year in January-September as it racked up strong revenues with four global brands including the antipsychotic agents Abilify Maintena (aripiprazole) and tolvaptan, a selective vasopressin V 2 receptor antagonist also...read more